Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 + 769 word(s) 769 2020-12-15 07:19:42

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Yin, N. Cleidocranial Dysplasia. Encyclopedia. Available online: (accessed on 04 December 2023).
Yin N. Cleidocranial Dysplasia. Encyclopedia. Available at: Accessed December 04, 2023.
Yin, Nicole. "Cleidocranial Dysplasia" Encyclopedia, (accessed December 04, 2023).
Yin, N.(2020, December 24). Cleidocranial Dysplasia. In Encyclopedia.
Yin, Nicole. "Cleidocranial Dysplasia." Encyclopedia. Web. 24 December, 2020.
Cleidocranial Dysplasia

Cleidocranial dysplasia is a condition that primarily affects development of the bones and teeth. Signs and symptoms of cleidocranial dysplasia can vary widely in severity, even within the same family.

genetic conditions

1. Introduction

Individuals with cleidocranial dysplasia usually have underdeveloped or absent collarbones, also called clavicles ("cleido-" in the condition name refers to these bones). As a result, their shoulders are narrow and sloping, can be brought unusually close together in front of the body, and in some cases can be made to meet in the middle of the body. Delayed maturation of the skull (cranium) is also characteristic of this condition, including delayed closing of the growth lines where the bones of the skull meet (sutures) and larger than normal spaces (fontanelles) between the skull bones that are noticeable as "soft spots" on the heads of infants. The fontanelles normally close in early childhood, but they may remain open throughout life in people with this disorder. Some individuals with cleidocranial dysplasia have extra pieces of bone called Wormian bones within the sutures.

Affected individuals are often shorter than other members of their family at the same age. Many also have short, tapered fingers and broad thumbs; flat feet; knock knees; short shoulder blades (scapulae); and an abnormal curvature of the spine (scoliosis). Typical facial features include a wide, short skull (brachycephaly); a prominent forehead; wide-set eyes (hypertelorism); a flat nose; and a small upper jaw.

Individuals with cleidocranial dysplasia often have decreased bone density (osteopenia) and may develop osteoporosis, a condition that makes bones progressively more brittle and prone to fracture, at a relatively early age. Women with cleidocranial dysplasia have an increased risk of requiring a cesarean section when delivering a baby, due to a narrow pelvis preventing passage of the infant's head.

Dental abnormalities are very common in cleidocranial dysplasia and can include delayed loss of the primary (baby) teeth; delayed appearance of the secondary (adult) teeth; unusually shaped, peg-like teeth; misalignment of the teeth and jaws (malocclusion); and extra teeth, sometimes accompanied by cysts in the gums.

In addition to skeletal and dental abnormalities, people with cleidocranial dysplasia may have hearing loss and are prone to sinus and ear infections. Some young children with this condition are mildly delayed in the development of motor skills such as crawling and walking, but intelligence is unaffected.

2. Frequency

Cleidocranial dysplasia occurs in approximately 1 per million individuals worldwide. It is likely underdiagnosed because many affected individuals have mild signs and symptoms.

3. Causes

Cleidocranial dysplasia is usually caused by mutations in the RUNX2 gene. This gene provides instructions for making a protein that is involved in the development and maintenance of teeth, bones, and cartilage. Cartilage is a tough, flexible tissue that makes up much of the skeleton during early development. Most cartilage is later converted to bone (a process called ossification), except for the cartilage that continues to cover and protect the ends of bones and is present in the nose, airways, and external ears.

The RUNX2 protein is a transcription factor, which means it attaches (binds) to specific regions of DNA and helps control the activity of particular genes. Researchers believe that the RUNX2 protein acts as a "master switch," regulating a number of other genes involved in the development of cells that build bones (osteoblasts) and in the development of teeth.

The RUNX2 gene mutations that cause cleidocranial dysplasia reduce or eliminate the activity of the protein produced from one copy of the RUNX2 gene in each cell, decreasing the total amount of functional RUNX2 protein. This shortage of functional RUNX2 protein interferes with the normal development of bones, cartilage, and teeth, resulting in the signs and symptoms of cleidocranial dysplasia. In rare cases, individuals with a deletion of genetic material that includes RUNX2 and other nearby genes may experience additional features, such as developmental delay, resulting from the loss of these genes.

In about 30 percent of individuals with cleidocranial dysplasia, no mutation in the RUNX2 gene has been found. The cause of the condition in these individuals is unknown.

4. Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. Some affected individuals inherit the mutation from one affected parent. Often the parent is mildly affected, and in some cases had not previously been recognized as having the disorder. Other cases result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.

5. Other Names for This Condition

  • cleidocranial dysostosis
  • dento-osseous dysplasia
  • Marie-Sainton syndrome


  1. Bruderer M, Richards RG, Alini M, Stoddart MJ. Role and regulation of RUNX2 inosteogenesis. Eur Cell Mater. 2014 Oct 23;28:269-86. Review.
  2. Bufalino A, Paranaíba LM, Gouvêa AF, Gueiros LA, Martelli-Júnior H, Junior JJ,Lopes MA, Graner E, De Almeida OP, Vargas PA, Coletta RD. Cleidocranialdysplasia: oral features and genetic analysis of 11 patients. Oral Dis. 2012Mar;18(2):184-90. doi: 10.1111/j.1601-0825.2011.01862.x.
  3. Cohen MM Jr. Biology of RUNX2 and Cleidocranial Dysplasia. J Craniofac Surg.2013 Jan;24(1):130-3. doi: 10.1097/SCS.0b013e3182636b7e. Review.
  4. D'Alessandro G, Tagariello T, Piana G. Cleidocranial dysplasia: etiology andstomatognathic and craniofacial abnormalities. Minerva Stomatol. 2010Mar;59(3):117-27. Review. English, Italian.
  5. Dinçsoy Bir F, Dinçkan N, Güven Y, Baş F, Altunoğlu U, Kuvvetli SS, PoyrazoğluŞ, Toksoy G, Kayserili H, Uyguner ZO. Cleidocranial dysplasia: Clinical,endocrinologic and molecular findings in 15 patients from 11 families. Eur J Med Genet. 2017 Mar;60(3):163-168. doi: 10.1016/j.ejmg.2016.12.007.
  6. Jaruga A, Hordyjewska E, Kandzierski G, Tylzanowski P. Cleidocranial dysplasiaand RUNX2-clinical phenotype-genotype correlation. Clin Genet. 2016Nov;90(5):393-402. doi: 10.1111/cge.12812.
  7. Machol K, Mendoza-Londono R, Lee B. Cleidocranial Dysplasia Spectrum Disorder.2006 Jan 3 [updated 2017 Nov 16]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE,Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Available from
  8. Roberts T, Stephen L, Beighton P. Cleidocranial dysplasia: a review of thedental, historical, and practical implications with an overview of the SouthAfrican experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013Jan;115(1):46-55. doi: 10.1016/j.oooo.2012.07.435.
  9. Ryoo HM, Wang XP. Control of tooth morphogenesis by Runx2. Crit Rev EukaryotGene Expr. 2006;16(2):143-54. Review.
  10. Stevenson DA, Carey JC, Byrne JL, Srisukhumbowornchai S, Feldkamp ML. Analysisof skeletal dysplasias in the Utah population. Am J Med Genet A. 2012May;158A(5):1046-54. doi: 10.1002/ajmg.a.35327.
  11. Vimalraj S, Arumugam B, Miranda PJ, Selvamurugan N. Runx2: Structure,function, and phosphorylation in osteoblast differentiation. Int J Biol Macromol.2015;78:202-8. doi: 10.1016/j.ijbiomac.2015.04.008.
  12. Wysokinski D, Pawlowska E, Blasiak J. RUNX2: A Master Bone Growth RegulatorThat May Be Involved in the DNA Damage Response. DNA Cell Biol. 2015May;34(5):305-15. doi: 10.1089/dna.2014.2688.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 277
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 24 Dec 2020